![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, July 10, 2020 4:26:49 PM
Reason: the trial may never start.
This is a real risk in nano-cap pharma stocks and a lot of big money won't touch them til a human trial is underway.
As we all know, there is a lot of hurdles in the way for a company before a human is ever dosed, and there is always the question of legitimacy, and the answer to that question becomes clear once a real drug enters the blood stream of a real live breathing ill homo-sapien. So far, the company has just tested mice..
Time will tell, 20 more days to start recruiting for phase 2b/3, and if they can't do that, we can declare another delay.
B. O. B.
Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM
UC Asset announces plan of management stock buyback • UCASU • Sep 3, 2024 9:00 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM